Ccc Intelligent Solutions Holdings Inc stock is traded at $2.48, with a volume of 3,628,834. It is up +1.64% in the last 24 hours and down -21.52% over the past month. C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
Previous Close:
$2.44
Open:
$2.39
24h Volume:
3,628,834
Relative Volume:
1.17
Market Cap:
$325.67M
Revenue:
$34.86M
Net Income/Loss:
-$103.80M
P/E Ratio:
-
EPS:
-$1.18
Net Cash Flow:
-$96.02M
1W Performance:
-10.14%
1M Performance:
-21.52%
6M Performance:
-24.39%
1Y Performance:
+4.20%
1-Day Range:
$2.32$2.55
1-Week Range:
$2.32$2.76
52-Week Range:
$1.69$5.17
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Company Profile
Name
Ccc Intelligent Solutions Holdings IncSector
HealthcareIndustry
BiotechnologyPhone
(617) 231-0700Address
490 ARSENAL WAY, WATERTOWN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS